Breaking Finance News

A report released today by BTIG Research about Tactile Systems Tech (NASDAQ:TCMD) raises the target price to $18.00

Stating a possible upside of 0.36%, BTIG Research raised the target price of Tactile Systems Tech (NASDAQ:TCMD) to $18.

Showing a price of $13.24, Tactile Systems Tech (NASDAQ:TCMD) traded 4.61% higher on the day. The last stock close is down 40.08% relative to the two hundred day average, compared to the S&P 500 which has decreased -0.01% over the date range. The company has logged a 50-day average of $13.93 and 200-day average of $13.93. Trading volume was was up over the average, with 255,001 shares of TCMD changing hands over the typical 117,782 shares.

See Chart Below:

Tactile Systems Tech (NASDAQ:TCMD)

Tactile Systems Tech has a PE of 315 with a one-year low of $10.00 and a 52 week high of $20.05 and has a market cap of $0.0.

Brief Synopsis On Tactile Systems Tech (NASDAQ:TCMD)

Tactile Systems Technology, Inc. is a United States-based medical technology company. The Company develops and provides medical devices for the treatment of chronic diseases at home. The Company markets its Flexitouch, ACTitouch and Entre systems, as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. Its Flexitouch System is a fully-automated, programmable, advanced pneumatic compression device, which is designed for treatment of lymphedema in the home setting. Its Flexitouch System consists of an electronic controller unit that offers over 10 treatment settings and multiple contoured garment configurations for the trunk and the arm or leg. Its ACTitouch System consists of a compression sleeve, a control unit, an undersock and a power adapter or charger. Its Entre System is a basic pneumatic compression device used for the at-home treatment of venous disorders, including lymphedema and chronic venous insufficiency, and including venous leg ulcers.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *